Paloma Partners Management CO Alnylam Pharmaceuticals, Inc. Transaction History

Paloma Partners Management CO

$3.08 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$143.31 - $247.0 $411,586 - $709,384	-2,872 Reduced 88.37%	378 $91,000
Q1 2024 May 15, 2024	BUY	$146.51 - $198.2 $476,157 - $644,150	3,250 New	3,250 $485,000
Q3 2023 Nov 14, 2023	BUY	$170.77 - $211.65 $10,929 - $13,545	64 New	64 $11,000
Q1 2023 May 15, 2023	BUY	$182.66 - $235.53 $96,992 - $125,066	531 New	531 $106,000
Q3 2022 Nov 14, 2022	BUY	$138.54 - $232.0 $152,532 - $255,432	1,101 New	1,101 $220,000
Q4 2021 Feb 14, 2022	SELL	$159.56 - $209.29 $270,773 - $355,165	-1,697 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$169.75 - $207.73 $288,065 - $352,517	1,697 New	1,697 $320,000
Q4 2020 Feb 16, 2021	SELL	$122.97 - $147.0 $5.31 Million - $6.34 Million	-43,141 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$121.19 - $165.49 $5.23 Million - $7.14 Million	43,141 New	43,141 $6.28 Million
Q1 2020 May 15, 2020	SELL	$93.12 - $133.99 $1.91 Million - $2.75 Million	-20,534 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$74.51 - $124.23 $1.53 Million - $2.55 Million	20,534 New	20,534 $2.37 Million
Q4 2018 Feb 14, 2019	SELL	$62.67 - $88.33 $247,922 - $349,433	-3,956 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$87.52 - $122.67 $562,666 - $788,645	-6,429 Reduced 61.91%	3,956 $345,000
Q2 2018 Aug 14, 2018	BUY	$88.31 - $107.8 $917,099 - $1.12 Million	10,385 New	10,385 $1.02 Million
Q1 2018 May 15, 2018	SELL	$115.92 - $148.54 $270,673 - $346,840	-2,335 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$114.49 - $139.98 $1.33 Million - $1.62 Million	-11,588 Reduced 83.23%	2,335 $297,000
Q3 2017 Nov 14, 2017	BUY	$72.53 - $118.27 $1.01 Million - $1.65 Million	13,923	13,923 $1.64 Million

Others Institutions Holding ALNY

# of Institutions

644

Shares Held

109M

Call Options Held

1.28M

Put Options Held

1.21M

Capital World Investors Los Angeles, CA

16.5M
Shares

$4.05 Billion
0.73% of portfolio
Vanguard Group Inc Valley Forge, PA

12.6M
Shares

$3.1 Billion
0.06% of portfolio
Black Rock Inc. New York, NY

9.55M
Shares

$2.34 Billion
0.05% of portfolio
Capital Research Global Investors Los Angeles, CA

5.24M
Shares

$1.29 Billion
0.31% of portfolio
Wellington Management Group LLP Boston, MA

4.95M
Shares

$1.21 Billion
0.24% of portfolio

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $30.2B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Paloma Partners Management CO with notifications on news.

Account